Latest Piperazines Stories
NORTHBROOK, Ill., April 23, 2015 /PRNewswire/ -- Astellas announced today that seven abstracts will be presented on CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, at the 25th
More women with high-grade serous ovarian cancer could benefit from drug, according to Maurie Markman, M.D. Plainsboro, NJ (PRWEB) April 20, 2015 The
- On track to file INDs for BLU-285 and initiate clinical studies in mid-2015 - CAMBRIDGE, Mass., April 19, 2015 /PRNewswire/ -- Blueprint Medicines today announced new preclinical data demonstrating
Trial is the first to study schizophrenia treatment within the context of many real-world issues faced by patients with schizophrenia TITUSVILLE, N.J., April 15, 2015 /PRNewswire/ -- A study
DeepResearchReports.com adds "Global and China Olanzapine Industry 2015 Research Report" , "2015 Global Quetiapine Fumarate Industry Report" and "Global Montelukast Sodium Industry 2015 - 2020" Research
Results served as basis for regulatory filing with U.S.
Coalition highlights momentum behind campaign for approval of first-ever drug for women's sexual dysfunction, launches new website for supporters to contact their elected representatives
- Treatment for Major Depressive Disorder (MDD) in Adults- DUBLIN, March 16, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced the U.S.
BRISTOL, Tenn., March 4, 2015 /PRNewswire/ -- UPM Pharmaceuticals, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with Sprout Pharmaceuticals to manufacture Flibanserin
EAST SETAUKTET, N.Y., Feb. 25, 2015 /PRNewswire/ -- Lixte Biotechnology Holdings Inc.
- A serpent whose bite was fabled to produce intense thirst.